ICIs Do Not Improve Outcomes in Low PD-L1–Expressing Gastric or Esophageal Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma
J. Clin. Oncol 2021 Dec 03;[EPub Ahead of Print], JJ Zhao, DWT Yap, YH Chan, BKJ Tan, CB Teo, NL Syn, EC Smyth, YY Soon, R SundarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.